| |   |  | | | | Wealth Management Presentation February 13th, 2013 The following presentation was given by Bill Witte and David Dodson of Salem Partners Wealth Management to the Professional Advisory Network for the Motion Picture & Television Fund on February 13th, 2013. Bill and David help decipher some of the major themes in the financial markets as well as some potential strategies that advisors and accountants can utilize to help their clients better manage these volatile and uncertain times.
| | | Salem Partners Advises ZS Pharma on $46 million Series C Financing FORT WORTH, TX – October 23, 2012 - Specialty pharmaceutical company ZS Pharma, Inc. has raised $46 million to advance development of ZS-9, a crystal form of zirconium silicate, designed to treat patients with kidney and liver disease.
Alta Partners led the new round of financing, joined by new investors RiverVest Venture Partners, 3x5 Special Opportunity Partners and Salem Partners as well as current investor Devon Park Bioventures. The funding will allow ZS Pharma to proceed with pivotal trials for ZS-9 as it prepares for commercialization of the product.
The ZS-9 compound selectively removes life-threatening toxins from patients suffering from kidney and liver disease and related conditions. Initial human clinical testing was focused on patients with elevated levels of potassium in their blood, a condition known as hyperkalemia.
“We are very excited to partner with our new investors to further develop novel treatments for hyperkalemia and other unmet medical needs,” said Dr. Al Guillem, president and CEO.
In conjunction with this financing, Robert Alexander, general partner, Alta Partners and John McKearn, managing partner, RiverVest Venture Partners, will join the ZS Pharma Board of Directors.
“We view ZS-9 as a significant medical advance which has the potential to provide major benefits to patients suffering from hyperkalemia,“ said Alexander.
ZS Pharma has further plans to research and develop other compounds targeting kidney and liver disease, conditions known to have limited treatment options today.
About ZS Pharma Founded in 2008, ZS Pharma, Inc. is a privately held specialty pharmaceutical company located in Fort Worth, Texas. It is focused on the development and commercialization of proprietary oral sorbent technology that will significantly improve the clinical outcomes of those patients suffering from toxic conditions associated with kidney and liver disease. About Salem Partners Founded in 1997, Salem Partners (www.salempartners.com) is a Los Angeles-based investment bank and wealth management firm. The firm’s investment banking practice provides capital raising and merger & acquisition advisory services to companies in the media and entertainment, life sciences, technology and aerospace and defense industries. Salem Partners Wealth Management provides investment advisory and other services to wealthy individuals, families and foundations. | | | Salem Partners Advises North American Aircraft Services & Mangrove Equity Partners on Acquisition of AOG, Inc. SAN ANTONIO, TX – January 11, 2012 - North American Aircraft Services, Inc. ("NAAS") along with its partner, Mangrove Equity Partners ("Mangrove"), have completed the acquisition of Aircraft On Ground, Inc. ("AOG"), a member of Taurus Aerospace Group and a portfolio company of Macquarie Capital. The transaction represents the marriage of two of the most well-respected aircraft fuel tank services companies in the industry today. Los Angeles-based Salem Partners acted as the exclusive investment banking advisor to NAAS and Mangrove Equity. Terms of the transaction were not disclosed. “Bringing AOG into the NAAS family was an essential move to grow operations and develop internal synergies in order to bring added value to our combined efforts, our customers and the global industry we serve,” cited Scott Hagler, president of NAAS. “The addition of over 120 technicians, along with an expanded European presence, dramatically enhances our ability to address customer needs.” David Watson, president of AOG, added “As the companies integrate, we look forward to providing the industry with new, complementary services that will be earmarked by the same superior quality and workmanship that customers have come to expect from both NAAS and AOG.”
Hunter Reichert of Mangrove is bullish on the event. “Mangrove invested in NAAS to help its management create a premier, international, aircraft services provider, and the acquisition of AOG represents our first bold step in that direction.”
About Salem Partners Founded in 1997, Salem Partners (www.salempartners.com) is a Los Angeles-based investment bank and wealth management firm. The firm’s investment banking practice provides capital raising and merger & acquisition advisory services to companies in the media and entertainment, life sciences, technology and aerospace and defense industries. Salem Partners Wealth Management provides investment advisory and other services to wealthy individuals, families and foundations. | | | Salem Partners Supports LA's Promise 2011 Gala LOS ANGELES, CA – September 28, 2011 - LA’s promise, a nonprofit working to radically shift the education, health and social outcomes for youth in South Los Angeles, held its 2011 Gala on Tuesday, September 27th at Hollywood’s Kodak Theater. Salem Partners is proud to have been a title sponsor of the event and even prouder that Salem’s co-founder, Stephen Prough, and his wife, Marina Berti, were event chairs for the unforgettable evening. Along with highlighting the incredible achievements of LA’s Promise, Ryan Seacrest and Mayor Antonio Villaraigosa were honored for their deep commitment to service and education. Mr. Prough, who has served on LA’s Promise’s Board of Directors since 2008, stated in his opening remarks, “We do what we do because we can envision the positive impact of 20,000 healthy, successful and college-ready students in this community; one characterized now by poverty, crime, low educational attainment, and growing health disparities…We are committed to using our public schools to anchor a neighborhood turnaround in the 8.2 square mile enrollment zone in South Los Angeles we call the LA’s Promise Neighborhood.” In attendance with over 2,000 other supporters, Salem’s co-founder, John Dyett, stated, “LA’s Promise is an extremely impressive organization that is making bold steps to better the community. Our firm is very proud to be a supporter of that mission.” About LA’s Promise LA’s Promise is a leader in the national school turnaround movement, showing undeniable results, rapid improvements and early dramatic gains. To learn more about LA’s Promise visit www.laspromise.org. About Salem Partners Founded in 1997, Salem Partners (www.salempartners.com) is a Los Angeles-based investment bank and wealth management firm. The firm’s investment banking practice provides capital raising and merger & acquisition advisory services to companies in the media and entertainment, life sciences, technology and aerospace and defense industries. Salem Partners Wealth Management provides investment advisory and other services to wealthy individuals, families and foundations. | | | Salem Partners Advises North American Aircraft Services in Its Recapitalization with Mangrove Equity Partners SAN ANTONIO, TX - August 22nd, 2011- North American Aircraft Services (“NAAS”), a privately held provider of fuel tank maintenance services to the aerospace industry, has completed a recapitalization with Mangrove Equity Partners. Salem Partners acted as the exclusive investment banking advisor to NAAS. About North American Aircraft Services Based in San Antonio, TX NAAS and its subsidiaries provide specialized aerospace services with a focus on fuel tank maintenance and repair. The company’s customer base includes both military and commercial aviation organizations such as Boeing, PEMCO, TIMCO and ST Engineering. In addition to its core services, NAAS provides composite manufacturing through its subsidiary, Turbomach LLC. With 14 locations, including international operations in Panama and Europe, NAAS employs approximately 200 personnel. For more information, please visit: www.naasinc.com. About Mangrove Equity Partners Mangrove Equity Partners, L.P. is a Tampa, Florida based lower middle market private equity fund. From its captive equity fund, Mangrove sponsors owners and operators in management buy-outs, management buy-ins, majority recapitalizations, family succession recaps, and industry consolidations. For more information, please visit: www.mangroveequity.com. About Salem Partners Founded in 1997, Salem Partners is a Los Angeles-based investment bank and wealth management firm that provides capital raising and merger & acquisition advisory services to companies in the media and entertainment, life sciences, technology and aerospace and defense industries. For more information, please visit: www.salempartners.com. | | | Rob Santos Joins Salem's Wealth Management Group LOS ANGELES, CA – August 15th, 2011– Salem Partners, a leading Los Angeles-based investment bank and wealth management firm, has expanded its senior team by appointing Rob Santos as Director of Development and Client Relations of its wealth management group as well as Salem’s SW Contego Fund, LLC, a fund of hedge funds established by the Wealth Management Group in 2008.The announcement was made today by Stephen Prough, Co-founder of Salem Partners. Salem Partners Wealth Management oversees investments for a number of high net worth individuals, families and foundations. Salem Partners Wealth Management manages clients' portfolios of stocks, bonds and alternative assets in addition to assisting with estate planning, real estate purchases and sales, credit needs and other financial matters. “We are delighted to welcome Rob onto the Salem team. Rob’s integrity, experience and energy will play a key role in the growth of the firm,” said Prough along with Salem Partners co-founder John Dyett. “Talent is one of the most important aspects of our ability to outperform for our clients and with over ten years of wealth management experience, Rob is a great reflection of the depth and skill we continue to add to the firm in support of our clients.” Prior to joining Salem Partners, Mr. Santos worked as an institutional fixed income salesman for JP Morgan Securities, where he serviced public bodies, money management firms and registered investment advisors. Prior to working in institutional fixed income, Mr. Santos held the position of Senior Analyst for a billion dollar wealth management team at JP Morgan Securities, where he was responsible for asset allocation, due diligence and client service. Mr. Santos currently sits on the Board of Directors for the Los Angeles Leadership Academy and the Los Angeles Child Development Center. Mr. Santos is a graduate of the University of California at Los Angeles. He currently holds the NASD Series 7 and 66 licenses. “Salem Partners is unique in its wealth of expertise, independence and quality of clients. I couldn’t be more thrilled to join the firm,” said Mr. Santos. About Salem Partners Founded in 1997, Salem Partners (www.salempartners.com) is a Los Angeles-based investment bank and wealth management firm. The firm’s investment banking practice provides capital raising and merger & acquisition advisory services to companies in the media and entertainment, life sciences, technology and aerospace and defense industries. Salem Partners Wealth Management provides investment advisory and other services to wealthy individuals, families and foundations. | | | Salem Partners advises KaZaK Composites, Inc. in its sale to Plasan Sasa Ltd. WOBURN, MA – June 28th, 2011– KaZaK Composites, Inc. a privately-held provider of advanced composite engineering services and manufacturing for the military defense industry has completed a sale to Plasan Sasa Ltd., an Israeli-based developer and manufacturer of armor systems for military and commercial markets using composite material technologies. Salem Partners acted as the exclusive investment banking advisor to KaZaK. “Dr. Fanucci and I are pleased to announce the sale of KaZaK. We believe that Plasan is an ideal partner to continue our tradition of engineering excellence and world-class manufacturing capabilities,” stated Executive Vice President, John Schickling. About KaZaK Composites Based in Woburn, MA, KaZaK has established itself as a leading provider of sophisticated composite engineering and manufacturing to the defense industry with a customer base that includes General Dynamics, Raytheon and Boeing. The Company serves a wide range of platforms and end-markets that include combat ships, unmanned aerial vehicles, military vehicles and missile systems. The business was founded in 1992 by Dr. Jerry Fanucci. About Plasan Plasan Sasa Ltd. engages in the research, design, development, and manufacture of lightweight survivability solutions for tactical combat vehicles, fixed-winged and rotary aircraft, naval platforms, civilian armored vehicles and personal protection. It offers armor kits, armor panel kits, chassis-up products, cab replacements, kitted hulls, and armored airborne solutions. The company was founded in 1985 and is based in M.P Merom Hagalil, Israel. About Salem Partners Salem Partners is a Los Angeles based investment bank and wealth management firm that provides capital raising and merger & acquisition advisory services to companies in the media and entertainment, life sciences, technology and aerospace and defense industries. For more information, please visit: www.salempartners.com. | | | Salem Partners advises KaZaK Composites, Inc. in its sale to Plasan Sasa Ltd. WOBURN, MA – June 28th, 2011– KaZaK Composites, Inc. a privately-held provider of advanced composite engineering services and manufacturing for the military defense industry has completed a sale to Plasan Sasa Ltd., an Israeli-based developer and manufacturer of armor systems for military and commercial markets using composite material technologies. Salem Partners acted as the exclusive investment banking advisor to KaZaK. “Dr. Fanucci and I are pleased to announce the sale of KaZaK. We believe that Plasan is an ideal partner to continue our tradition of engineering excellence and world-class manufacturing capabilities,” stated Executive Vice President, John Schickling. About KaZaK Composites Based in Woburn, MA, KaZaK has established itself as a leading provider of sophisticated composite engineering and manufacturing to the defense industry with a customer base that includes General Dynamics, Raytheon and Boeing. The Company serves a wide range of platforms and end-markets that include combat ships, unmanned aerial vehicles, military vehicles and missile systems. The business was founded in 1992 by Dr. Jerry Fanucci. About Plasan Plasan Sasa Ltd. engages in the research, design, development, and manufacture of lightweight survivability solutions for tactical combat vehicles, fixed-winged and rotary aircraft, naval platforms, civilian armored vehicles and personal protection. It offers armor kits, armor panel kits, chassis-up products, cab replacements, kitted hulls, and armored airborne solutions. The company was founded in 1985 and is based in M.P Merom Hagalil, Israel. About Salem Partners Salem Partners is a Los Angeles based investment bank and wealth management firm that provides capital raising and merger & acquisition advisory services to companies in the media and entertainment, life sciences, technology and aerospace and defense industries. For more information, please visit: www.salempartners.com. | | | IBM Buying Lombardi Software
December 16, 2009 -- IBM has agreed to acquire Lombardi Software, an Austin, Texas-based developer of business process management software. No financial terms were disclosed. Lombardi has raised around $78 million in VC funding, from firms like Austin Ventures, InterWest Partners and Palomar Ventures.
| | Salem Partners Establishes Aerospace & Defense Industry Practice
LOS ANGELES, CA - June 2009 - Salem Partners, a Los Angeles-based investment bank and wealth management firm, is pleased to announce the establishment of its Aerospace and Defense Industry Practice with the acquisition of industry veterans Trevor Bohn and Ryan Murphy.
“For years Salem has been widely regarded as a thought leader in both the Life Sciences and Entertainment industries,” said John Dyett, co-founder and Managing Director. “We wanted to broaden our influence in the middle market, and targeted Aerospace and Defense as a key industry to do so.”
Co-founder Stephen Prough added, “Trev and Ryan bring a unique combination of industry and operational expertise, deep strategic relationships and substantial international experience. Their leadership will give Salem Partners the kind of immediate credibility that is required to be a player in middle market Aerospace & Defense advisory services.”
Trevor Bohn, has amassed over a decade of A&D investment banking experience from Bank of America Securities LLC and McGladrey Capital Markets. “In a dynamic global supply chain, clients are looking for more than just plain vanilla M&A. Salem’s broad line of services will allow us to provide tailored solutions for our clients,” says Bohn.
Founded in 1997, Salem Partners (www.salempartners.com) is a Los Angeles-based investment bank and wealth management firm. The firm's investment banking practice represents independent and major media and entertainment conglomerates and growing companies in the technology and life sciences industries. Salem Partners Wealth Management provides investment advisory and other services to wealthy individuals, families and foundations.
| | Salem Partners Wealth Management Ranked 22nd Nationally in Wealth Manager Magazine’s Annual Rankings
LOS ANGELES, CA - July 18, 2008 - Salem Partners Wealth Management (“SPWM”) has been ranked in the top 25 wealth management firms in the U.S. by Wealth Manager Magazine in their “Eighth Annual Wealth Manager Top Dogs Report.” Improving from last year, SPWM also ranked as the top firm in Los Angeles and fifth in the State of California. SPWM was founded in 2003 as a sister company to Salem Partners LLC, a Los Angeles-based investment banking firm. SPWM provides investment advisory and wealth management services for ultra-high net worth clients across the country. Both SPWM and Salem Partners are privately held. “We are pleased to be included in this year’s rankings,” said David Dodson, Director of Salem Partners Wealth Management. “Capital preservation is a key goal for our clients, and we are happy to have continued momentum in light of the difficult market conditions all firms are facing,” added John Dyett, co-founder of both SPWM and Salem Partners. “Our goal continues to be top ranked portfolio performance in all market environments, while never deviating from the high level of service we constantly seek to provide our clients,” said Stephen Prough, also co-founder of both firms. “We feel our inclusion in the ranking again this year validates our ability to meet this goal.” Wealth Manager Magazine’s annual rankings take into account the total assets a firm has under management as well as the total number of clients. Nearly 500 independent advisory firms were considered for the 2008 rankings.
The full report can be found in the July/August issue of Wealth Manager or online at www.wealthmanagermag.com. Salem Partners Wealth Management is a Registered Investment Advisor (RIA). | | Salem Partners Wealth Management Ranked 24th Nationally in Wealth Manager Magazine’s Annual Rankings
Salem Partners Wealth Management (“SPWM”) has been ranked in the top 25 advisory firms in the U.S. by Wealth Manager Magazine in their 2007 rankings. SPWM also ranked second in Los Angeles and seventh in the State of California.
SPWM was founded in 2003 as a sister company to Salem Partners LLC, a Los Angeles-based investment banking firm. SPWM provides investment advisory and wealth management services for ultra-high net worth clients across the country. Both SPWM and Salem Partners are privately held.
“We are honored to be considered for this ranking,” said Stephen Prough, co-founder of SPWM and Salem Partners. “We have desired from the outset to build a wealth management firm that provides clients with unparalleled investment expertise, attention to detail and service.”
“We are pleased to be recognized in this way,” added John Dyett, also a co-founder of both SPWM and Salem Partners. “We have always put our clients first, and we are glad that they continue to reward us with their business.”
Wealth Manager Magazine’s annual rankings take into account the total assets a firm has under management as well as the total number of clients. Over 500 independent advisory firms were considered in the 2007 rankings.
Salem Partners Wealth Management is a Registered Investment Advisor (RIA). | | Acquisition of Adams Respiratory Therapeutics by Reckitt Benckiser for $2.3 Billion in Cash
CHESTER, N.J. and SLOUGH, London, December 10, 2007 /PRNewswire-FirstCall/ -- Reckitt Benckiser Group plc (RB.L) ("Reckitt Benckiser") and Adams Respiratory Therapeutics ("Adams") today announce that they have entered into a definitive agreement under which Reckitt Benckiser will tender for the acquisition of Adams for $60 per share in cash, representing a total consideration for Adams' fully diluted share capital of approximately $2.3bn (1.1bn pounds Sterling). This transaction will be financed by Reckitt Benckiser by cash on hand and existing credit facilities.
Adams is a NASDAQ listed specialty pharmaceutical company, headquartered in Chester New Jersey, USA. Adams is exclusively focused on the development, commercialisation and marketing of pharmaceuticals for the treatment of respiratory disorders. Adams is currently active in the United States only and markets two brands; Mucinex(R), market leader in adult expectorants and Delsym(R), a leading cough suppressant. Mucinex represents most of Adams' sales.
Adams' net sales have grown from $14m in the fiscal year ending June 2003 to $332m for the fiscal year ending June 2007. A key driver of the company's growth has been the approval by the FDA in 2002 of the Mucinex patent protected extended-release guaifenesin product for chest congestion relief. Income before income taxes for the year ending June 2007 was $48m.
Adams is a specialty pharmaceutical company focused on the late-stage development, commercialisation and marketing of OTC and prescription pharmaceuticals for the treatment of respiratory disorders. In the fiscal year ending June 2007, Adams had net sales of $332m, income before income taxes of $48m (as reported), and gross assets of $318m under US GAAP. Adams financials will be restated onto Reckitt Benckiser policies on completion.
Adams has a manufacturing facility in Fort Worth, Texas for the production of adult Mucinex. Delsym is produced for Adams under a manufacturing supply agreement.
Adams has grown rapidly in recent years, with compound growth of net sales over the period Fiscal Year 2005- 2007 of 44%, and continuing growth to date in Q1 of the fiscal year to June 2008 of 22%.
The company has approximately 500 employees.
Reckitt Benckiser is headquartered in Slough just outside London, UK and is listed on the London stock exchange. With a market capitalization of c. 20bn pounds it ranks among the top 25 UK listed companies. Reckitt Benckiser had net revenues of 4.92bn pounds, operating profit of 910m pounds and net income of 674m pounds in 2006.
For more details, please go to http://www.drugs.com/news/acquisition-adams-respiratory-therapeutics-reckitt-benckiser-7361.html. | | Kabillion, LLC Completes Private Placement with EM.TV Salem Partners LLC is pleased to announce that Kabillion, LLC has closed a private placement for an undisclosed sum with EM.TV, a publicly-traded, Munich-based entertainment and sports company. Kabillion is a multi-platform children's entertainment production and distribution company that debuted January 2007 on the Comcast video-on-demand service, and on the web at www.kabillion.com. Kabillion creates and distributes via television, the Internet and mobile services animated programs such as Bobby's World, featuring Howie Mandel, and Mixmaster King of Cards. Salem Partners acted as an exclusive placement agent for the Company.
For more details, please go to http://www.marketwire.com/mw/release_html_b1?release_id=203342. | | Quinnova Pharmaceuticals, Inc. Completes $13.6 Million Series A Financing NEWTOWN, P.A. - November 28, 2006 - Quinnova Pharmaceuticals, Inc., a specialty dermatological pharmaceutical company focused on the development and commercial sale of prescription drug products based on innovative dermal drug delivery platforms, announced today that it has completed a $13.6 million Series A round of private financing. Participating in the financing are Thomas, McNerney & Partners, H.I.G. Ventures and an investor syndicate led by Omnivest (Bermuda) Ltd.
"We are very proud of Quinnova's progress in the relatively short time since the company's inception and the fact that this progress has allowed the company to attract an outstanding group of investors whose expertise and reach add tremendous value to Quinnova on a 'go forward' basis," stated Jeffrey S. Day, President, Chief Executive Officer and co-founder of Quinnova. "The funds raised in this financing will allow us to accelerate the development of our product pipeline and introduce the company's first dermatological prescription drug products to market in 2007."
As a result of the financing, three new members have joined Quinnova's board of directors: Alex Zisson, partner at Thomas McNerney & Partners, Aaron Davidson, managing director of H.I.G. Ventures, and Frits Besselaar, corporate officer of Omnivest (Bermuda) Ltd.
"We're very pleased to be backing Jeff and Chris, and helping to prepare for Quinnova's first commercial launches next year," stated Alex Zisson. "We also see a great opportunity to invest in the company's delivery platforms and assure a continual stream of new products in the future."
"Our investment in Quinnova represents an exciting opportunity to build a new company focused on the high growth market for dermatological products," stated Frits Besselaar. "We look forward to working closely with the company in an effort to maximize the potential for its current and future pipeline of products."
John Dyett of Salem Partners, LLC, served as the company's placement agent, and handling the transaction for Quinnova was Christopher S. Brennan, the company's EVP Operations, General Counsel and co-founder, as well as Ella DeTrizio and Sara Bucholtz from Dechert LLP. Thomas, McNerney & Partners and H.I.G. Ventures were represented by Kristopher Brown and Jesse Yeo from Ropes & Gray LLP and Omnivest (Bermuda) Ltd. was represented by Todd Johnston and Matthew Weingast of Drinker Biddle & Reath LLP.
About Quinnova Pharmaceuticals, Inc.
Quinnova Pharmaceuticals, Inc. is a specialty dermatological pharmaceutical company focused on the development and commercial sale of prescription drug products based on in-licensed dermal drug delivery platforms. The company employs a "reformulation strategy" whereby already-proven safe and effective pharmaceutical ingredients are delivered, either individually or in combination, in unique, effective, convenient, cosmetically elegant and patent protected delivery systems. By employing this strategy, the company will use its own sales force to bring dermatological prescription drug products to the commercial market on a relatively short development timeline by significantly reducing the regulatory hurdles for entrance into the marketplace for a substantial portion of its product pipeline. Additionally, the company's portfolio of versatile drug delivery systems lends itself to out-licensing and corporate partnering opportunities beyond the core portfolio of drug products that the company itself develops. For more information, please visit: www.quinnova.com.
About Thomas, McNerney & Partners
Thomas, McNerney & Partners, LLC, is a health care private equity firm that invests in life science and medical technology companies. Employing a multi-stage investment approach, Thomas, McNerney & Partners has just under $600 million in assets under management and provides seed and early stage funding to help entrepreneurs launch companies, as well as growth capital to emerging companies for furthering clinical development or for expansion of product commercialization. For more information, please visit: www.tm-partners.com.
About H.I.G. Ventures
H.I.G. Ventures partners with entrepreneurs to provide the capital, expertise and relationships necessary to build market-leading businesses. With over $550 million in dedicated venture capital under management, the firm's team invests nationally in early, mid and growth-stage information technology and life sciences businesses. H.I.G. Ventures is the venture capital affiliate of H.I.G. Capital, a leading private equity investment firm with over $3 billion of capital under management. H.I.G. Ventures has offices in Atlanta and Miami. For more information, visit www.higventures.com. About Omnivest (Bermuda) Ltd.
Omnivest (Bermuda) Ltd. is an investment holding company based in Bermuda and is advised by Princeton Investment Advisors, Inc. (PIA), which is located in Princeton, New Jersey. Omnivest's multi-million dollar investment portfolio consists of a variety of onshore and offshore investments. PIA was founded in 1992 by Mr. Frits Besselaar who is the company's current president and chief investment officer. During Mr. Besselaar's tenure at PIA, Omnivest has invested in many highly successful investment partnerships, with investment mandates that have focused on distressed debt, convertible arbitrage, event driven transactions, long/short equity, private equity and buy-outs.
About Salem Partners LLC
Salem Partners is a Los Angeles based investment bank which provides capital raising and merger & acquisition advisory services to companies in the life sciences, technology and media industries. Founded in 1997, Salem Partners has completed transactions with aggregate value of over $3 billion. For more information, please visit: www.salempartners.com. |
| Salem Partners Wealth Management Hires David Dodson as Director, Wealth Management Salem Partners, a leading Los Angeles-based investment bank and wealth management firm, has appointed David Dodson as a director of its wealth management group. Salem Partners Wealth Management provides customized investment solutions in a multi-family office environment. Previously a Vice President of Essential Advisers, Inc., Mr. Dodson has been a wealth management professional for ten years during which time he has advised families with a diverse set of interests, backgrounds and financial assets. For Salem, Mr. Dodson will lead the firm's wealth management practice together with head of operations Goli Kamangar and Salem Partners founders Stephen Prough and John Dyett. Mr. Dodson will oversee the firm's investment and asset allocation team. "We are delighted to welcome someone as experienced as David to our wealth management practice. David's focus on client service as well as his energy and enthusiasm for the business makes him a perfect fit for the Salem Partners culture," said Stephen Prough, co-founder of Salem Partners. "David is the ideal leader for our wealth management team. His experience in all aspects of serving the business and financial interests of families will ensure that our clients continue to receive the best possible advice and attention regarding their financial lives," said John Dyett, also a co-founder of the firm. "I am excited to be a part of the Salem Partners' Wealth Management team. The sophistication and energy the firm brings to servicing its clients is infectious. I look forward to applying my expertise and adding value in every way I can to benefit our clientele," said Mr. Dodson. Mr. Dodson joins Salem after serving as Vice President and Portfolio Manager for Essential Advisers, Inc., a wealth management firm in Denver serving ultra affluent investors. While at Essential, Mr. Dodson was responsible for the design, implementation and management of Essential's client portfolios, deploying a wealth of investment and analytical skills for the benefit of clients. Additionally, Mr. Dodson designed and managed Essential's disciplined Large Cap Growth stock portfolio and played an integral role in serving clients. Before joining Essential Advisers, David was Director of Investment Planning for a billion dollar investment management firm in Overland Park, Kansas. Mr. Dodson holds a Masters of Science in Finance degree from the University of Denver and a Bachelor of Science in Business Administration from the University of Kansas, is a Chartered Financial Analyst Charterholder, a Certified Financial Planner® Certificant and a member of the Denver Society of Securities Analysts. Founded in 1997, Salem Partners (www.salempartners.com ) is a leading Los Angeles-based investment bank and wealth management firm. The firm's investment banking practice represents independent and major media and entertainment conglomerates and growing companies in the technology and life sciences industries. Recent transactions completed by Salem Partners include the $160 million sale of the film and television library of Crown Media Holdings, Inc. to RHI Entertainment and the $13.6 million private placement of Series A preferred stock for Quinnova Pharmaceuticals, Inc. Salem Partners Wealth Management provides integrated wealth management services for highly affluent individuals, families and foundations. | | Crown Media Holdings, Inc. Enters Into Definitive Agreement To Sell Its Film and Television Library to RHI Enterprises, LLC for $160 Million We are pleased to announce that Crown Media Holdings, Inc. has entered into a definitive agreement to sell its film and television library to RHI Enterprises, LLC for $160 million in cash. Through the transaction, RHI Enterprises, LLC has acquired various rights to film and television properties including The Odyssey, Lonesome Dove, the Farscape series, Gulliver's Travels, the Quintex / Hal Roach library titles including Topper, Laurel and Hardy titles, and Little Rascals titles, and other libraries from Kushner Locke and Cabin Fever, among others. Salem Partners, LLC acted as financial advisor to Crown Media Holdings, Inc. in connection with the transaction. Read Company press release. | |
| | | | | | |
